{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:50:02Z","timestamp":1780375802880,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002345"],"award-info":[{"award-number":["UL1 TR002345"]}],"id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AI38385"],"award-info":[{"award-number":["1R21AI38385"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24 HS19455"],"award-info":[{"award-number":["R24 HS19455"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR002346"],"award-info":[{"award-number":["KL2 TR002346"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.06.020","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T23:42:23Z","timestamp":1592523743000},"page":"5178-5186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease"],"prefix":"10.1016","volume":"38","author":[{"given":"J. Bradley","family":"Layton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Sahrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas R.","family":"Dharnidharka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"O'Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-6864","authenticated-orcid":false,"given":"Anne M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2020.06.020_b0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1681\/ASN.2018060581","article-title":"Excess deaths attributable to influenza-like illness in the ESRD population","volume":"30","author":"Gilbertson","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.vaccine.2020.06.020_b0010","unstructured":"Chi C, Patel P, Pilishvili T, Moore M, Murphy T, Strikas R. Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease. Centers for Disease Control and Prevention 2012. Available at: https:\/\/www.cdc.gov\/vaccines\/pubs\/downloads\/dialysis-guide-2012.pdf [accessed: 10 June 2019]."},{"issue":"7","key":"10.1016\/j.vaccine.2020.06.020_b0015","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archinternmed.2011.2238","article-title":"Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment","volume":"172","author":"McGrath","year":"2012","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.020_b0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/aje\/kwu485","article-title":"Controlling time-dependent confounding by health status and frailty: Restriction versus statistical adjustment","volume":"182","author":"McGrath","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"41","key":"10.1016\/j.vaccine.2020.06.020_b0025","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1016\/j.vaccine.2018.08.079","article-title":"High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010\u20132013","volume":"36","author":"McGrath","year":"2018","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2020.06.020_b0030","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1016\/j.vaccine.2007.08.042","article-title":"Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects","volume":"25","author":"Couch","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.020_b0035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.vaccine.2012.12.013","article-title":"High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009\u20132010 season","volume":"31","author":"DiazGranados","year":"2013","journal-title":"Vaccine"},{"issue":"51","key":"10.1016\/j.vaccine.2020.06.020_b0040","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2015.10.131","article-title":"Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50\u201364 years of age","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.06.020_b0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older","volume":"200","author":"Falsey","year":"2009","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2020.06.020_b0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archinte.166.10.1121","article-title":"Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons","volume":"166","author":"Keitel","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2020.06.020_b0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14760584.2019.1575734","article-title":"Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis","volume":"18","author":"Samson","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.06.020_b0060","doi-asserted-by":"crossref","unstructured":"Kaka AS, Filice GA, Myllenbeck S, Nichol KL. Comparison of side effects of the 2015-2016 high-dose, inactivated, trivalent influenza vaccine and standard dose, inactivated, trivalent influenza vaccine in adults >\/=65 years. Open Forum Infect Dis 2017; Winter;4(1):ofx001.","DOI":"10.1093\/ofid\/ofx001"},{"issue":"11","key":"10.1016\/j.vaccine.2020.06.020_b0065","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/cid\/cis256","article-title":"postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the vaccine adverse event reporting system, 1 July 2010-31 December 2010","volume":"54","author":"Moro","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2020.06.020_b0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmi.2018.05.002","article-title":"Immunogenicity and reactogenicity of high- vs. standard-dose trivalent inactivated influenza vaccine in healthcare workers: a pilot randomized controlled trial","volume":"25","author":"Volling","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2020.06.020_b0075","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/ndt\/gfq782","article-title":"Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients","volume":"26","author":"Labriola","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.vaccine.2020.06.020_b0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-94-007-4549-0_35","article-title":"Immune response to influenza vaccine in hemodialysis patients with chronic renal failure","volume":"756","author":"Mastalerz-Migas","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2020.06.020_b0085","unstructured":"U.S. Renal Data System. 2019 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2019. Available at: https:\/\/www.usrds.org\/adr.aspx."},{"key":"10.1016\/j.vaccine.2020.06.020_b0090","unstructured":"Update: influenza activity--United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb Mortal Wkly Rep 2011; 60(21):705\u201312."},{"key":"10.1016\/j.vaccine.2020.06.020_b0095","unstructured":"Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine. MMWR Morb Mortal Wkly Rep 2012; 61(22):414\u201320."},{"key":"10.1016\/j.vaccine.2020.06.020_b0100","unstructured":"Influenza activity--United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2013; 62(23):473\u20139."},{"issue":"21","key":"10.1016\/j.vaccine.2020.06.020_b0105","first-page":"583","article-title":"Influenza activity - United States, 2014\u201315 season and composition of the 2015\u201316 influenza vaccine","volume":"64","author":"Appiah","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2020.06.020_b0110","first-page":"483","article-title":"Influenza activity - United States, 2013\u201314 season and composition of the 2014\u201315 influenza vaccines","volume":"63","author":"Epperson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2020.06.020_b0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm6522a3","article-title":"Influenza activity - United States, 2015\u201316 season and composition of the 2016\u201317 influenza vaccine","volume":"65","author":"Davlin","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"10.1016\/j.vaccine.2020.06.020_b0120","doi-asserted-by":"crossref","first-page":"668","DOI":"10.15585\/mmwr.mm6625a3","article-title":"Update: Influenza activity in the United States during the 2016\u201317 season and composition of the 2017\u201318 influenza vaccine","volume":"66","author":"Blanton","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.vaccine.2020.06.020_b0125","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.020_b0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pds.3719","article-title":"Using claims data to predict dependency in activities of daily living as a proxy for frailty","volume":"24","author":"Faurot","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.vaccine.2020.06.020_b0135","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/pds.4435","article-title":"Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches","volume":"27","author":"Conover","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"25","key":"10.1016\/j.vaccine.2020.06.020_b0140","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2020.06.020_b0145","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. Available at: http:\/\/www.R-project.org\/."},{"key":"10.1016\/j.vaccine.2020.06.020_b0150","unstructured":"US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis; 2019."},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.020_b0155","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jval.2013.05.008","article-title":"Treatment dynamics of newly marketed drugs and implications for comparative effectiveness research","volume":"16","author":"Gagne","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2020.06.020_b0160","doi-asserted-by":"crossref","unstructured":"Butler AM, Layton JB, Krueger WS, Kshirsagar AV, LJ M. Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness: Comparison of High-dose versus Standard Dose Vaccines. Medical Care 2019; 57(1):73\u20138.","DOI":"10.1097\/MLR.0000000000001018"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.020_b0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ajkd.2019.05.018","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccine among patients receiving maintenance hemodialysis","volume":"75","author":"Butler","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.06.020_b0170","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2215\/CJN.03390318","article-title":"High-dose seasonal influenza vaccine in patients undergoing dialysis","volume":"13","author":"Miskulin","year":"2018","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:16:09Z","timestamp":1777536969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":34,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307933"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}